AVTR Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

10.570

Open

10.490

VWAP

10.27

Vol

6.93M

Mkt Cap

6.96B

Low

10.045

Amount

71.20M

EV/EBITDA(TTM)

11.65

Total Shares

682.76M

10.62B

EV/OCF(TTM)

18.52

P/S(TTM)

1.08

Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.

Events Timeline

No data

News

6.5

07-05Yahoo Finance

Avantor Stock Valuation Analysis

9.5

07-01PRnewswire

Avantor to Release Q2 2026 Financial Results on July 29

9.5

07-01Newsfilter

Avantor Announces Q2 2026 Financial Results Release Schedule

6.0

06-09NASDAQ.COM

Avantor Inc Stock Surpasses Analyst Target Price

5.0

05-19PRnewswire

Avantor Appoints New Executive VP of Quality and Regulatory

5.0

05-19Newsfilter

Avantor Appoints New Executive VP of Quality and Regulatory

7 Analyst Rating

Wall Street analysts forecast AVTR stock price to rise

1 Buy

4 Hold

2 Sell

Hold

Current: 0.000

Low

8.00

Averages

11.67

High

16.00

Current: 0.000

Low

8.00

Averages

11.67

High

16.00

Evercore ISI

In Line

maintain

AI Analysis

2026-07-06

New

Reason

Evercore ISI

Price Target

AI Analysis

2026-07-06

New

maintain

In Line

Reason

Evercore ISI raised the firm's price target on Avantor to $10.50 from $8 and keeps an In Line rating on the shares. The firm's Q2 preview for MedTech, Life Sciences Tools, and Diagnostics highlights generally healthy procedure volumes and capital expenditure trends across the sector, the analyst tells investors in a research note.

Bernstein

Market Perform

initiated

$10.50

2026-06-26

Reason

Bernstein

Price Target

$10.50

2026-06-26

initiated

Market Perform

Reason

Bernstein resumed coverage of Avantor with a Market Perform rating and $10.50 price target following a return from maternity leave. \"Many things\" are going right for the life science tools and diagnostics sector, the analyst tells investors in a research note. The firm says new drug approvals, trial starts, and funding are all better in the last 12 months versus the 12 months prior. Bernstein believes funding will start translating into customer spend while re-shoring will drive incremental investment at a time when AI-driven demand for semiconductor-related tools will continue to grow.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AVTR

Unlock Now

Valuation Metrics

The current forward P/E ratio for Avantor Inc (AVTR.N) is 13.14, compared to its 5-year average forward P/E of 19.00. For a more detailed relative valuation and DCF analysis to assess Avantor Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

19.00

Current PE

13.14

Overvalued PE

24.35

Undervalued PE

13.65

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

17.92

Current EV/EBITDA

12.73

Overvalued EV/EBITDA

31.57

Undervalued EV/EBITDA

4.26

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

2.04

Current PS

1.06

Overvalued PS

2.66

Undervalued PS

1.41

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

stocks with biggest losses

Intellectia · 43 candidates

Market Cap: >= 300.00MRegion: USPrice: >= $2.00Volume: >= 300,000Price Change Pct: <= $-10.00List Exchange: XNYS, XNAS, XASE

Ticker

Name

Market Cap$

Unity Software Inc

9.27B

MAT

Mattel Inc

4.91B

ANGI

Angi Inc

396.99M

LEU

Centrus Energy Corp

4.13B

Zillow Group Inc

10.92B

LYFT

Lyft Inc

5.61B

best 3 stocks under $20 to buy tomorrow

Intellectia · 166 candidates

Market Cap: >= 500.00MPrice: <= $20.00Beta: ModerateRiskWeekly Average Turnover: >= 1,000,000Rsi 14: 30 - 70

Ticker

Name

Market Cap$

LYG

Lloyds Banking Group PLC

81.38B

NWG

NatWest Group PLC

70.55B

STLA

Stellantis NV

37.25B

NOK

Nokia Oyj

35.71B

ERIC

Telefonaktiebolaget LM Ericsson

31.60B

WIT

Wipro Ltd

27.24B

Whales Holding AVTR

Eversept Partners, L.P.

First Pacific Advisors, LP

Arlington Value Capital, LLC

Barrow, Hanley, Mewhinney & Strauss, LLC

Trading Trends

People Also Watch

Frequently Asked Questions

What is Avantor Inc (AVTR) stock price today?

The current price of AVTR is 10.2 USD — it has decreased -1.64

What is Avantor Inc (AVTR)'s business?

What is the price predicton of AVTR Stock?

Wall Street analysts forecast AVTR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTR is11.67 USD with a low forecast of 8.00 USD and a high forecast of 16.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.